2246
I. Malik et al.
LETTER
(3) (a) Su, B.; Hackett, J. C.; Diaz-Cruz, E. S.; Kim, Y. W.;
Brueggemeier, R. W. Bioorg. Med. Chem. 2005, 13, 6571.
(b) Kim, Y. W.; Hackett, J. C.; Brueggemeier, R. W. J. Med.
Chem. 2004, 47, 4032. (c) Traxler, P.; Green, J.; Mett, H.;
Sequin, U.; Furet, P. J. Med. Chem. 1999, 42, 1018.
(d) Cushman, M.; Zhu, H.; Geahlen, R. L.; Kraker, A. J.
J. Med. Chem. 1994, 37, 3353.
(4) For reviews of cross-coupling reactions of polyhalogenated
heterocycles, see: (a) Schröter, S.; Stock, C.; Bach, T.
Tetrahedron 2005, 61, 2245. (b) Schnürch, M.; Flasik, R.;
Khan, A. F.; Spina, M.; Mihovilovic, M. D.; Stanetty, P. Eur.
J. Org. Chem. 2006, 3283.
(5) (a) Dang, T. T.; Dang, T. T.; Ahmad, R.; Reinke, H.; Langer,
P. Tetrahedron Lett. 2008, 49, 1698. (b) Dang, T. T.;
Villinger, A.; Langer, P. Adv. Synth. Catal. 2008, 350, 2109.
(c) Hussain, M.; Nguyen, T. H.; Langer, P. Tetrahedron Lett.
2009, 50, 3929. (d) Tengho Toguem, S.-M.; Hussain, M.;
Malik, I.; Villinger, A.; Langer, P. Tetrahedron Lett. 2009,
50, 4962. (e) Dang, T. T.; Dang, T. T.; Rasool, N.; Villinger,
A.; Langer, P. Adv. Synth. Catal. 2009, 351, 1595.
(6) (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457.
(b) Miyaura, N. Top. Curr. Chem. 2002, 219, 11.
isolated as a crystalline light yellow solid (148 mg, 74%),
mp 248–249 °C. 1H NMR (300 MHz, CDCl3): d = 2.19 (s, 3
H, CH3), 2.29 (s, 3 H, CH3), 6.75 (s, 1 H), 6.90–7.04 (m, 8
H, ArH), 7.24–7.33 (m, 3 H, ArH), 7.39 (d, 1 H, J = 8.2 Hz,
ArH), 7.48–7.51 (m, 2 H, ArH), 8.16 (d, 1 H, J = 8.2 Hz,
ArH). 13C NMR (75MHz, CDCl3): d = 21.2, 21.4 (CH3),
106.7 (CH), 122.8 (C), 124.4, 126.2, 127.4, 128.6, 128.7,
128.9, 129.7 (CH), 130.2 (C), 131.0, 131.4 (CH), 131.6,
131.7, 137.0, 137.1, 146.7, 153.9, 163.2, 178.6 (C). IR
(KBr): n = 2917 (w), 1631 (m), 1592 (w), 1446, 1371 (m),
1238 (w), 1145, 1016 (m), 917 (w), 816, 773, 690 (s), 665
(m) cm–1. GC-MS (EI, 70 eV): m/z (%) = 402 (100) [M+],
387 (34), 359 (3), 331 (4), 299 (4), 285 (7), 243 (9), 229 (12).
HRMS (EI): m/z calcd for C29H22O2 [M+]: 402.16143; found:
402.161442.
(12) 7-(4-Ethylphenyl)-4-oxo-2-phenyl-4H-chromen-8-yl
Trifluoromethanesulfonate (5a)
Starting with 2 (156 mg, 0.30 mmol), K3PO4 (96 mg, 0.45
mmol), Pd(PPh3)4 (5 mol%), (4-ethylphenyl)boronic acid
(3a, 45 mg, 0.30 mmol), and 1,4-dioxane (3mL), 5a was
isolated as a white solid (102 mg, 72%), mp 167–168 °C. 1H
NMR (500 MHz, CDCl3): d = 1.22 (t, 3 H, J = 7.7 Hz, CH3),
2.66 (q, 2 H, J = 7.5 Hz, CH2), 6.83 (s, 1 H), 7.27 (d, 2 H,
J = 8.0 Hz, ArH), 7.38 (d, 2 H, J = 8.3 Hz, ArH), 7.44 (d, 1
H, J = 8.3 Hz, ArH), 7.46–7.50 (m, 3 H, ArH), 7.95–7.97 (m,
2 H, ArH), 8.18 (d, 1 H, J = 8.3 Hz, ArH). 13C NMR (125.76
MHz, CDCl3): d = 15.5 (CH3), 28.7 (CH2), 108.2 (CH),
118.0 (q, JF,C = 320 Hz, CF3), 124.2 (C), 125.1, 126.7, 127.4,
128.3, 129.1, 129.2 (CH), 130.8, 131.6 (C), 132.1 (CH),
135.1, 140.7, 145.9, 149.0, 163.8, 176.7 (C). 19F NMR (282
MHz, CDCl3): d = –74.3. IR (KBr): n = 2916, 2850 (w),
1622, 1568, 1447 (m), 1386 (s), 1271 (m), 1164 (s), 1041
(m), 906 (w), 811, 767, 681 (s), 634 (w) cm–1. GC-MS (EI,
70 eV): m/z (%) = 474 (40) [M+], 410 (28), 395 (18), 366 (3),
341 (100), 326 (8), 313 (20), 281 (4). HRMS (EI): m/z calcd
for C24H17F3O5S [M+]: 474.07471; found: 474.07492.
(13) 8-(4-Ethylphenyl)-2-phenyl-7-(p-tolyl)-4H-chromen-4-
one (6a)
(7) Nawaz, M.; Ibad, M. F.; Obaid-Ur-Rahman, A.; Khera,
R. A.; Villinger, A.; Langer, P. Synlett 2010, 150.
(8) (a) Zembower, D.; Zhang, H. J. Org. Chem. 1998, 63, 9300.
(b) Zheng, X.; Meng, W.; Qing, F. Tetrahedron Lett. 2004,
45, 8083. (c) Huang, X.; Tang, E.; Xu, W. M.; Cao, J.
J. Comb. Chem. 2005, 7, 802. (d) Peng, W.-J.; Han, X.-W.;
Yu, B. Chin. J. Chem. 2006, 24, 1154.
(9) Synthesis of 4-Oxo-2-phenyl-4H-chromene-7,8-diyl-
bis(trifluoromethanesulfonate (2)
To a CH2Cl2 solution (10 mL) of 1 (254 mg, 1.0 mmol) was
added pyridine (0.32 mL, 4.0 mmol) at –78 °C under argon
atmosphere. After stirring for 10 min, Tf2O (0.40 mL, 2.4
mmol) was added at –78 °C. The mixture was allowed to
warm to 0 °C and stirred for 4 h. The reaction mixture was
filtered, and the filtrate was concentrated in vacuo. Product
2 was isolated by rapid column chromatography (flash silica
gel, heptanes–EtOAc) as a white solid (393 mg, 76%), mp
142–143 °C. 1H NMR (300 MHz, CDCl3): d = 6.82 (s, 1 H),
7.43–7.52 (m, 4 H, ArH), 7.88–7.91 (m, 2 H, ArH), 8.25 (d,
J = 9.4 Hz, 1 H). 13C NMR (75.5 MHz, CDCl3): d = 108.3
(CH), 118.6 (q, JF,C = 321.6 Hz, CF3), 118.7 (q, JF,C = 320.4
Hz, CF3), 118.9 (CH), 124.7 (C), 126.6, 126.7, 129.3 (CH),
129.9, 130.2 (C), 132.6 (CH), 143.9, 149.5, 164.5, 175.3 (C).
19F NMR (282 MHz, CDCl3): d = –72.66, –72.85. IR (KBr):
n = 3080 (w), 1660 (s), 1613 (m), 1427 (s), 1359 (m), 1210,
1126 (s), 1053, 996, 955, 836, 794, 756 (m), 733 (w), 684
(m) cm–1. GC-MS (EI, 70 eV): m/z (%) = 518 (95) [M+], 385
(7), 357 (15), 321 (29), 293 (100), 219 (66), 191 (79). HRMS
(EI, 70 eV): m/z calcd for C17H8F6O8S2 [M+]: 517.95700;
found: 517.95651.
Following the general procedure starting with 5c (101 mg,
0.22 mmol), K3PO4 (93 mg, 0.44 mmol), Pd(PPh3)4 (5
mol%), 4-(ethylphenyl)boronic acid (3a, 44 mg, 0.29
mmol), and 1,4-dioxane (3 mL), 6a was isolated as a yellow
solid (60 mg, 66%), mp 198–199 °C. 1H NMR (500 MHz,
CDCl3): d = 1.20 (t, 3 H, J = 7.9 Hz, CH3), 2.23 (s, 3 H,
CH3), 2.62 (q, 2 H, J = 7.5 Hz), 6.79 (s, 1 H), 6.95–7.01 (m,
4 H, ArH), 7.07–7.12 (m, 4 H, ArH), 7.26–7.38 (m, 3 H,
ArH), 7.43 (dd, 1 H, J = 3.4, 8.3 Hz, ArH), 7.50–7.54 (m, 2
H, ArH), 8.18 (d, 1 H, J = 8.3 Hz, ArH). 13C NMR (125.75
MHz, CDCl3): d = 15.8, 21.1 (CH3), 28.7 (CH2), 122.8 (C),
124.3, 126.2, 127.4, 128.6, 128.7, 128.8, 128.9, 129.6,
131.0, 131.3 (CH), 131.6, 131.7, 132.0, 137.0, 143.5, 146.5,
146.7, 153.9, 136.1, 178.7 (C). IR (KBr): n = 2962, 2923,
1644 (s), 1597 (w), 1371 (m), 1202, 1096, 1016 (w), 815,
771 (m), 688 (w) cm–1. GC-MS (EI, 70 eV): m/z (%) = 416
(100) [M+], 402 (16), 387 (49), 313 (6), 285 (14), 271 (5),
253 (6), 239 (9). HRMS (EI): m/z calcd for C30H24O2 [M+]:
416.17783; found: 416.17762.
(10) General Procedure for Suzuki–Miyaura Cross-Coupling
Reactions
A 1,4-dioxane solution (3–4 mL) of 2 (1.0 equiv),
arylboronic acid 3 (1.0–1.3 equiv per desired cross-coupling
reaction), K3PO4 (1.5–2.0 equiv per desired cross-coupling
reaction), and Pd(PPh3)4 (5 mol%) was heated at 70–100 °C
for 4 h. After cooling to 20 °C, a sat. aq solution of NH4Cl
was added, the organic and aqueous layers were separated,
and the latter was extracted with CH2Cl2. The combined
organic layers were dried (Na2SO4), filtered, and the filtrate
was concentrated in vacuo. The residue was purified by
column chromatography.
(14) CCDC-781627 contains all crystallographic details of
this publication and is available free of charge at
ordered from the following address: Cambridge
Crystallographic Data Centre, 12 Union Road,
GB-Cambridge CB21EZ; fax: +44 (1223)336033; or
(11) 2-Phenyl-7,8-di(p-tolyl)-4H-chromen-4-one (4f)
Starting with 2 (259 mg, 0.5 mmol), K3PO4 (424 mg, 2.0
mmol), Pd(PPh3)4 (5 mol%), 4-methylphenylboronic acid
(3f, 177 mg, 1.3 mmol), and 1,4-dioxane (5 mL), 4f was
(15) For a simple guide for the prediction of the site-selectivity of
palladium(0)-catalyzed cross-coupling reactions based on
the 1H NMR chemical shift values, see: Handy, S. T.; Zhang,
Y. Chem. Commun. 2006, 299.
Synlett 2010, No. 15, 2244–2246 © Thieme Stuttgart · New York